Transforming Patient Care by Replacing Injections with Safer,
More Effective Therapeutics Given Orally
Revolutionizing
Oral Biologics Delivery
Transforming Patient Care by
Replacing Injections with Safer,
More Effective Therapeutics Given Orally

Enabling Technologies for Precision Drug Delivery in the GI Tract

Soteria

Soteria® is a revolutionary new technology that allows patients to take biopharmaceutical drugs, including monoclonal antibodies, as a simple and safe tablet or capsule.

Phloral

Phloral® is a cutting-edge technology for precise and consistent delivery to the colon. It exploits changes in gastrointestinal pH in combination with the enzymatic activity of the microbiota as independent but complementary release mechanisms to guarantee site-specific release.

Pipeline of Oral Biologics

Featured News

Intract Pharma Enters into Research Collaboration with Ferring Pharmaceuticals to Evaluate Oral delivery of Monoclonal Antibodies for Treatment of Chronic Gastrointestinal Diseases

Intract Pharma and NIBEC Enter into an Agreement to Develop a Novel Oral Peptide Therapy for Treatment of Ulcerative Colitis.

Intract Pharma Limited and Celltrion Group announce collaboration for development of oral Infliximab.